Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Century Therapeutics (IPSC)

Century Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IPSC
DateTimeSourceHeadlineSymbolCompany
15/05/202421:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IPSCCentury Therapeutics Inc
10/05/202412:00GlobeNewswire Inc.Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
09/05/202412:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/05/202412:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IPSCCentury Therapeutics Inc
09/05/202412:30GlobeNewswire Inc.Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
07/05/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/05/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/05/202422:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/05/202421:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
23/04/202412:00GlobeNewswire Inc.Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:IPSCCentury Therapeutics Inc
11/04/202412:00GlobeNewswire Inc.Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade TherapeuticsNASDAQ:IPSCCentury Therapeutics Inc
08/04/202421:05GlobeNewswire Inc.Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
25/03/202411:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:IPSCCentury Therapeutics Inc
19/03/202411:00GlobeNewswire Inc.Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:IPSCCentury Therapeutics Inc
14/03/202411:30GlobeNewswire Inc.Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
08/03/202423:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/03/202421:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/03/202421:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/03/202423:03GlobeNewswire Inc.Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
21/02/202421:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
21/02/202418:04Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IPSCCentury Therapeutics Inc
16/02/202421:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/02/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
07/02/202422:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
06/02/202421:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/02/202420:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
01/02/202412:00GlobeNewswire Inc.Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IPSCCentury Therapeutics Inc
19/01/202422:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
11/12/202315:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
09/12/202317:00GlobeNewswire Inc.Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ EditsNASDAQ:IPSCCentury Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IPSC